跳至主要内容
临床试验/IRCT201202183236N2
IRCT201202183236N2已完成未知

The effect of pomegranate extract on clinical index, inflammation markers and oxidative stress of Rheumatoid Arthritis patient in 1390

Vice chancellor for research OF Shiraz university of medical sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Rheumatoid arthritis patients which their disease diagnosed according to the revised American Rheumatism Association criteria, ages between 18-65 years old, RA patients who don’t have enough clinical and laboratory response to conventional disease modifying anti rheumatic drugs (Methotrexate, Hydroxychloroquine, Sulphasalazine, and prednisolone), No drug type and dose fluctuation since 1 month prior to the study and during intervention period.
  • Exclusion criteria: Presence of Chronic disease such as diabetes, cardiovascular, hepatic, kidney, gastrointestinal diseases, and severe infection, smoking, Alcohol consumption, use of supplements (antioxidants, multivitamins,...), patients with known allergy and food intolerance.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research OF Shiraz university of medical sciences

相似试验